A Prospective Quality of Life Study in Men With Clinically Localized Prostate Carcinoma Treated With Different Treatment Modalities
43 Years
82 Years
Male
Prostate Cancer
Trial Information
A Prospective Quality of Life Study in Men With Clinically Localized Prostate Carcinoma Treated With Different Treatment Modalities
Quality of life is of great concern to patients considering treatment options for prostate
cancer. Patients with clinically localized prostate cancer treated with active surveillance,
radical prostatectomy, external radiotherapy and high intensity focused ultrasound were
included. All men completed the questionnaires of Functional Assessment of Cancer
Therapy-Prostate (FACT-P) (version 4), International Prostate Symptom Score (IPSS) and
International Index of Erectile Function (IIEF) before treatment and 1, 3, 6, 12 months
after treatment.
Inclusion Criteria:
- patients diagnosed with clinically localized prostate cancer
Exclusion Criteria:
- patients with another malignancies
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Health-related quality of life changes over time
Outcome Time Frame:
12 months after treatment
Safety Issue:
No
Principal Investigator
Han Yong Choi, professor
Investigator Role:
Principal Investigator
Investigator Affiliation:
Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine
Authority:
Korea: Food and Drug Administration
Study ID:
SMC IRB 2004-05-21
NCT ID:
NCT00777452
Start Date:
March 2005
Completion Date:
December 2007
Related Keywords:
- Prostate Cancer
- quality of life
- localized prostate cancer
- FACT-P
- Prostatic Neoplasms
Name | Location |
|---|
